Equities

BioAdaptives Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
BDPT:PKC

BioAdaptives Inc

Actions
  • Price (USD)0.0199
  • Today's Change0.001 / 4.74%
  • Shares traded2.50k
  • 1 Year change-78.19%
  • Beta1.1250
Data delayed at least 15 minutes, as of Feb 09 2026 18:45 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

BioAdaptives, Inc. operates in the health and wellness industry. The Company’s core business is to investigate, market and distribute natural plant, fungi, and algal based products and medical devices that improve health and wellness for humans and animals, with an emphasis on pain relief, anti-viral function, and anti-aging properties. Its products in development include a weight management supplement in a human clinical trial, Zeranovia. Zeranovia is made of natural ingredients and uses proprietary methods of optimizing the availability of nutrients in foods and beverages. Xcellara regenerative stem cell activator is in production. Xcellara is its regenerative wellness solution, to enhance performance, accelerate recovery, and revitalize health. PawPa Regen is the canine treat stem cell activator. PawPa Regen supports anti-aging and wellness. Its other products include MyndMed and Wynovia. MyndMed is designed to optimize multiple neurotransmitter systems and neuroprotective pathways.

  • Revenue in USD (TTM)7.85k
  • Net income in USD-1.11m
  • Incorporated2013
  • Employees1.00
  • Location
    BioAdaptives Inc2620 Regatta Drive, Suite 102LAS VEGAS 89128United StatesUSA
  • Phone+1 (702) 659-8829
  • Fax+1 (302) 645-1280
  • Websitehttps://www.bioadaptives.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Blue Star Foods Corp2.60m-10.55m53.09k11.00------0.0205-1.24-1.240.1831-0.08290.56971.813.67235,941.80-231.60-77.54-604.34-290.2829.753.65-406.53-79.850.3389-9.60-----41.32-31.50-179.06--62.28--
North America Frac Sand Inc0.00-226.72k71.91k3.00---------85.49-85.490.00-306.24------0.00---5,915.30-----------193.66---16.94-----100.00--142.25------
Netbrands Corp7.11k-1.59m116.22k1.00------16.35-0.0296-0.02960.0002-0.03230.2381-------5,324.68-1,009.64----51.3434.31-22,362.17-469.68---0.5364-----100.00--2.73------
Red Oak Hereford Farms Inc62.19m-5.59m233.98k22.00------0.0038-0.348-0.3483.88-0.12978.4116.1827.742,826,727.00-73.96------3.70---8.80--0.5094-3.521.33--4.08--46.11------
Bioadaptives Inc7.85k-1.11m238.97k1.00------30.44-0.1207-0.12070.0009-0.1340.0920.1329--7,850.00-1,295.86-974.85----62.5540.40-14,093.50-4,659.250.0407-14.73-----55.654.99-26.20------
Limitless Venture Group Inc0.00-10.68m252.52k-----------117.82-117.820.00-9.89---------------------------37.95----------------
Energroup Holdings Corp222.19m20.42m322.37k793.000.05180.00930.01390.00150.96610.966110.515.401.4523.603.42302,297.6013.3111.6520.3716.5514.1515.419.196.051.9015.130.30810.0021.08---11.47------
NuVim Inc60.01k-350.92k536.02k3.00------8.93-0.0044-0.00440.0008-0.01320.57530.489723.9120,003.33-336.44-256.46----20.2025.31-584.77-200.880.0053-10.76-----51.24-35.0168.55------
Data as of Feb 09 2026. Currency figures normalised to BioAdaptives Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.